Jeff is the Managing Partner of Maytal Capital, a healthcare-focused private equity investment and advisory firm he founded, and an Operating Partner at Revival Healthcare Capital, a medical device-focused private equity firm. He serves on the board of directors at Amneal Pharmaceuticals (NYSE: AMRX), a leading specialty and generic pharmaceuticals company, and Roam Analytics, a Silicon Valley-based artificial intelligence healthcare software firm, as well as for several non-profit organizations including Education Opens Doors, where he serves as Chairman, and the North Texas Food Bank, one of the largest non-profits in the state.
Between 2008 and 2016, Jeff served on the Executive Committee of Novartis Group, a Fortune 50 pharmaceutical company based in Switzerland, first as Division Head & CEO of Sandoz (2008-2014), Novartis’s generic pharmaceuticals and biosimilars subsidiary (~$10 billion in sales) based in Germany, and then as Division Head & CEO of Texas-based Alcon (2014-2016), Novartis’s eye care subsidiary (~$10 billion in sales) which is now an independent company (NYSE: ALC). In both roles, he was responsible for leading over 25,000 associates globally across more than 160 countries and had primary line leadership and management responsibility for all functions, regions, and franchises. More recently he served as CEO and Board Director of Performance Health, a leader in consumer healthcare and the largest global manufacturer and distributor of products to the physical therapy and rehabilitation markets.
Earlier in his career, Jeff headed Emerging Markets (Middle East, Africa, Southeast Asia and CIS) at Novartis Pharmaceuticals, leading a team of over 3,000 people across 65 markets and serving on its Executive Committee. He previously served as Vice President and Head of Western & Eastern Europe for Novartis Vaccines. Before joining Novartis, Jeff was a Senior Director of Strategic Planning & Business Development at Gap Inc., and an Engagement Manager with McKinsey & Co., both in San Francisco.
Jeff holds an MBA from Harvard Business School and a master’s degree from Johns Hopkins University’s School of Advanced International Studies (SAIS), where he studied international economics and emerging markets political economy and was a John W. Watzek Fellow. He received his B.A. in international relations, magna cum laude and Phi Beta Kappa, from Carleton College.
Jeff has been a member of the Young Presidents’ Organization (YPO) since 2012, where he serves on the Dallas Board, and served on the Board of Directors for AdvaMed, the medical device industry association, between 2014 and 2016. He was twice named to Fortune magazine’s “40 under 40” list of up-and-coming leaders. Jeff is married with two daughters and enjoys running, skiing, live music, yoga, meditation, travel, and foreign affairs.